advertisement

---

Reinehr S 7

Showing records 1 to 7 | Display all abstracts from Reinehr S

84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Reinehr S
Frontiers in pharmacology 2019; 10: 1381

---

84995 Current State of Primary Neuroprotection in Glaucoma
Reinehr S; Grotegut P
Klinische Monatsblätter für Augenheilkunde 2020; 237: 143-149

---

84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Gomes SC; Gassel CJ
Frontiers in pharmacology 2019; 10: 1381

---

84995 Current State of Primary Neuroprotection in Glaucoma
Tsai T; Wagner N
Klinische Monatsblätter für Augenheilkunde 2020; 237: 143-149

---

84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Asaad MA
Frontiers in pharmacology 2019; 10: 1381

---

84995 Current State of Primary Neuroprotection in Glaucoma
Joachim SC
Klinische Monatsblätter für Augenheilkunde 2020; 237: 143-149

---

84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Stute G; Schargus M; Dick HB; Joachim SC
Frontiers in pharmacology 2019; 10: 1381

---